GSK cuts HIV/AIDS drug prices, Latin America cuts drug deal

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.418, 2003-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug prices affect access to HIV/AIDS drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 398, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Revised reimbursement drug prices reflect price cuts in Japan

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 256, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Generic AIDS drug deal settled by GSK and Boehringer in S Africa

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 444, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

OTC market potential, HIV drug price cuts in India

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 368, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Greece begins drug price cuts

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 612, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite